Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

Clinical trial NCT07223229 · RECRUITING

Trial details

NCT number: NCT07223229
Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-segmental Vitiligo

Start date: 2025-12-30
Primary completion: 2026-12-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.